Intranasal creatine prodrug shows early brain activity in phase 1 trial
A phase 1 trial found that intranasal creatine prodrug CBT101 was tolerated and produced exploratory EEG changes consistent with central ...
A phase 1 trial found that intranasal creatine prodrug CBT101 was tolerated and produced exploratory EEG changes consistent with central ...
Kansai Medical University Hospital gave the first worldwide dose of investigational CD25-directed antibody drug conjugate DS1025 in a global Phase ...
A pilot study shows a needle-free blood collection device can sustain nine venous samples per visit through a single IV ...
A Phase 1 trial found that an eight-week dosing interval produced stronger and longer-lasting antibody responses against H5N1 influenza than ...
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
A Phase 1 trial found that combining the ATR inhibitor ceralasertib with the PARP inhibitor olaparib was generally well tolerated ...
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
The phase 1 GlutaPanc trial shows that l-glutamine can be safely combined with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ...
An investigational EGFR x HER3 antibody-drug conjugate showed promising efficacy and a manageable safety profile in previously treated EGFR-mutated lung ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine